Beone Medicines Ltd. Class A · SSE:688235
Baker Bros. Advisors LP exercised options for 30,768 Beone Medicines Ltd. Class A shares (Form 4)
Traded Sep 14, 2026 · Filed Sep 16, 2026
On Sep 14, 2026, Baker Bros. Advisors LP (Director) exercised options for 30,768 Beone Medicines Ltd. Class A shares at US$36.83 for US$1.13M, leaving 8,099,179 shares. Filed Sep 16, 2026 (Form 4).
- Options exercised
- 30,768 shares
- Price
- US$36.83
- Value
- US$1.13M
- Holding after
- 8,099,179 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | American Depositary Shares | Option exercise | 30,768 | US$36.83 | 8,099,179 | Indirect |
Source
Related
- Beone Medicines Ltd. Class A
- Baker Bros. Advisors LP
- Beone Medicines Ltd. Class A shareholders
- Form 4 · Baker Bros. Advisors LP · May 27, 2026
- Form 4 · Wang Xiaodong · Oct 15, 2026
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 16, 2026
- Form 4 · Wang Xiaodong · Sep 10, 2026